183
Participants
Start Date
November 18, 2016
Primary Completion Date
March 11, 2021
Study Completion Date
March 11, 2021
Leiden University Medical Center, Leiden
Medizinische Universität Graz, Graz
Memorial Sloan Kettering Cancer Center, New York
Istituto Nazionale Tumori-Foundazione IRCCS, Milan
Istituto Ortopedico Rizzoli, Bologna
Hospital Universitario Virgen del Rocio, Seville
CHU Nantes, Nantes
Westdeutsches Tumorzentrum, Essen
University of Texas MD Anderson Cancer Center, Houston
David Geffen School of Medicine at UCLA, Los Angeles
University of California San Francisco, San Francisco
Radboud universitair medisch centrum, Nijmegen
Hospital Sant Pau, Barcelona
The Royal Marsden Hospital, London
Nuffield Orthopaedic Centre, Oxford
Lead Sponsor
Collaborators (1)
Optimapharm
INDUSTRY
Daiichi Sankyo
INDUSTRY